Home > Drug Search >
  • company_query: Baliopharm AG
  •   > 
Drug Filter
Category:
chemistry (4) biology (18)
Status:
Approved (2) BLA Filing (1) Phase Ⅲ (3) Phase Ⅱ (10) Phase Ⅰ (6)
Clinical Stage:
Pending (2) Active (15) Discontinued (3)
Bio-Type:
Coagulation factor (1) CAR T cell therapy (2) Whole antibody (4) ADC (1) Fusion protein (2)
Indication:
Breast cancer (2) Rectal cancer (1) Cutaneous T cell lymphoma (CTCL) (1) wound (1) Gastric cancer (3) HBV infection (1) Afibrinogenaemia (1) Lung cancer (1) Melanoma (1) Multiple myeloma (MM) (1) Non-Hodgkin’s lymphoma (NHL) (2) Ovarian cancer (1) Pancreatic cancer (2) Prostate cancer (1) Schizophrenia (1) Seasonal allergic rhinitis (1) Solid tumours (1) Head and neck cancer (1) Influenza A virus infections (1) Colorectal cancer (3) Neuroblastoma (1) Sickle cell disease (1) Hemophilia A (1) Neutropenia (1) Renal carcinoma (1) Autoimmune diseases (1) Glioblastoma (1) Allergic asthma (1) Thelassemia (1) Human papillomavirus infections (HPV) (1)
Country:
Aprv. Year:
2012 (1) 2017 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top